scholarly journals Response to comment on ‘Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial’

Eye ◽  
2011 ◽  
Vol 25 (6) ◽  
pp. 820-820 ◽  
Author(s):  
M L Subramanian
Keyword(s):  
Clinical Trial ◽  
Macular Degeneration ◽  
Randomised Clinical Trial ◽  
Age Related Macular Degeneration ◽  
Age Related

scholarly journals Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial

The Lancet ◽  
2015 ◽  
Vol 386 (10011) ◽  
pp. 2395-2403 ◽  
Author(s):  
Elizabeth P Rakoczy ◽  
Chooi-May Lai ◽  
Aaron L Magno ◽  
Matthew E Wikstrom ◽  
Martyn A French ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Gene Therapy ◽  
Macular Degeneration ◽  
Phase 1 ◽  
Randomised Clinical Trial ◽  
Age Related Macular Degeneration ◽  
Age Related

Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial

2018 ◽  
Vol 257 (1) ◽  
pp. 31-40 ◽  
Author(s):  
Geoffrey K. Broadhead ◽  
John R. Grigg ◽  
Peter McCluskey ◽  
Thomas Hong ◽  
Timothy E. Schlub ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Macular Degeneration ◽  
Randomised Clinical Trial ◽  
Age Related Macular Degeneration ◽  
Age Related

scholarly journals Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial

Eye ◽  
2010 ◽  
Vol 24 (11) ◽  
pp. 1708-1715 ◽  
Author(s):  
M L Subramanian ◽  
G Abedi ◽  
S Ness ◽  
E Ahmed ◽  
M Fenberg ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Macular Degeneration ◽  
Randomised Clinical Trial ◽  
Age Related Macular Degeneration ◽  
Age Related
Sign in / Sign up

Export Citation Format

Share Document